Log In
BCIQ
Print this Print this
 

BGB10C9

  Manage Alerts
Collapse Summary General Information
Company BerGenBio A/S
DescriptionMurine, high affinity Axl function-blocking mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic ductal adenocarcinoma (PDAC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today